87 related articles for article (PubMed ID: 23551774)
1. PET/CT mediastinal and liver FDG uptake: effects of biological and procedural factors.
Malladi A; Viner M; Jackson T; Mercier G; Subramaniam RM
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):169-75. PubMed ID: 23551774
[TBL] [Abstract][Full Text] [Related]
2. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
3. Impact of animal handling on the results of 18F-FDG PET studies in mice.
Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of whole-body F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with carcinoma of unknown primary.
Wang G; Wu Y; Zhang W; Li J; Wu P; Xie C
J Med Imaging Radiat Oncol; 2013 Feb; 57(1):65-71. PubMed ID: 23374557
[TBL] [Abstract][Full Text] [Related]
5. Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)?
Regier M; Derlin T; Schwarz D; Laqmani A; Henes FO; Groth M; Buhk JH; Kooijman H; Adam G
Eur J Radiol; 2012 Oct; 81(10):2913-8. PubMed ID: 22197090
[TBL] [Abstract][Full Text] [Related]
6. Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
van Laarhoven HW; de Geus-Oei LF; Wiering B; Lok J; Rijpkema M; Kaanders JH; Krabbe PF; Ruers T; Punt CJ; van der Kogel AJ; Oyen WJ; Heerschap A
Radiology; 2005 Oct; 237(1):181-8. PubMed ID: 16183932
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study.
Kaira K; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Hayashi I; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
Eur J Radiol; 2012 Sep; 81(9):2423-9. PubMed ID: 22055682
[TBL] [Abstract][Full Text] [Related]
8. The combined effects of serum lipids, BMI, and fatty liver on 18F-FDG uptake in the liver in a large population from China: an 18F-FDG-PET/CT study.
Liu G; Li Y; Hu P; Cheng D; Shi H
Nucl Med Commun; 2015 Jul; 36(7):709-16. PubMed ID: 25757200
[TBL] [Abstract][Full Text] [Related]
9. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
10. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
[TBL] [Abstract][Full Text] [Related]
11. [Variations of the hepatic SUV in relation to the body mass index in whole body PET-CT studies].
Batallés SM; Villavicencio RL; Quaranta A; Burgos L; Trezzo S; Staffieri R; Pezzotto SM
Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):26-32. PubMed ID: 23177341
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
[TBL] [Abstract][Full Text] [Related]
13. The influence of adipose tissue volume can significantly affect the metabolic activity of reference organs in
Yoo ID; Lee SM; Lee JW; Oh JE; Cho YJ; Shin HS
Hell J Nucl Med; 2017; 20(3):211-216. PubMed ID: 29177259
[TBL] [Abstract][Full Text] [Related]
14. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J
Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620
[TBL] [Abstract][Full Text] [Related]
15. Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
Li M; Wu N; Liu Y; Zheng R; Liang Y; Zhang W; Zhao P
Eur J Radiol; 2012 Aug; 81(8):1886-90. PubMed ID: 21511421
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of contrast medium enhancement and [(18)F]-FDG uptake of liver metastasis in PET/CT prior to therapy.
Hundt W; la Fougère C; Vogtmann J; Steinbach S; Burbelko M; Tiling R
Eur J Radiol; 2012 Apr; 81(4):652-7. PubMed ID: 21300504
[TBL] [Abstract][Full Text] [Related]
17. F-18 FDG PET/CT in the management of thyroid cancer.
Iagaru A; Kalinyak JE; McDougall IR
Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
[TBL] [Abstract][Full Text] [Related]
18. Active Brown Fat During
Gerngroß C; Schretter J; Klingenspor M; Schwaiger M; Fromme T
J Nucl Med; 2017 Jul; 58(7):1104-1110. PubMed ID: 28104743
[TBL] [Abstract][Full Text] [Related]
19. Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?
Keramida G; Dizdarevic S; Bush J; Peters AM
Eur Radiol; 2015 Sep; 25(9):2701-8. PubMed ID: 25899414
[TBL] [Abstract][Full Text] [Related]
20. Liver SULmean at FDG PET/CT: interreader agreement and impact of placement of volume of interest.
Viner M; Mercier G; Hao F; Malladi A; Subramaniam RM
Radiology; 2013 May; 267(2):596-601. PubMed ID: 23297330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
